Effects of gender and ethnic group on blood pressure control in the elderly

American Journal of Hypertension

Volumn 9, Issue 6, 1996, Pages 529-535

  Svetkey, Laura P ^a,c   George, Linda K ^a   Tyroler, Herman A ^b   Timmons, Phillip Z ^a   Burchett, Bruce M ^a   Blazer, Dan G ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b University of North Carolina at Chapel Hill   (United States)

^c DUKE UNIVERSITY   (United States)

Author keywords

Antihypertensive therapy; Blood pressure control; Elderly; Epidemiology; Ethnicity; Gender

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; VASODILATOR AGENT;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; DRUG EFFECT; ETHNIC GROUP; FEMALE; GENDER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE;

EID: 0030175806     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/0895-7061(96)00026-X     Document Type: Article

References (22)

1. 1. Landahl SK, Lernfelt B, Sundh V: Blood pressure and mortality in old age. Eleven years' follow-up of a 70-year-old population. J Hypertens 1987;5:745-748.
2. 2. Garland C, Barrett-Connor E, Suarez L, Criqui MH: Isolated systolic hypertension and mortality after age 60 years. Am J Epidemiol 1983;118:365-376.
3. 3. Curb JD, Borhani NO, Schnaper H, et al: Detection and treatment of hypertension in older individuals. Am J Epidemiol 1985;121:371-376.
4. 4. The Management Committee: The Australian Therapeutic trial in mild hypertension: treatment of mild hypertension in the elderly. Med J Aust 1981;2:398-402.
5. 5. SHEP Cooperative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the systolic hypertension in the elderly program (SHEP). JAMA 1991;265:3255-3264.
6. 6. Dahlöf B, Lindholm LH, Hansson L, et al: Morbidity and mortality in the Swedish trial in old patients with hypertension (STOP-hypertension). Lancet 1991; 338:1281-1285.
7. 7. Dahlöf B, Lindholm LH, Hansson L, et al: Five year findings of the Hypertension Detection and Followup Program II: mortality by race, sex and age. JAMA 1979; 242:2572-2577.
8. 8. Medical Research Council Working Party: Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992;304:405-412.
9. 9. Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. National Institutes of Health Publication No. 84-1088. US Dept. of Health and Human Services, Washington, DC, June, 1984.
10. 10. Svetkey LP, George LK, Burchett BM, et al: Black/ white differences in hypertension in the elderly: an epidemiologic analysis in central North Carolina. Am J Epidemiol 1993;137:64-73.
11. 11. The Trials of Hypertension Prevention Collaborative Research Group: The effects of nonpharmacologic interventions on blood pressure of persons with high normal levels. JAMA 1992;267:1213-1220.
12. 12. Devito CA, Aldridge GW, Wilson A, et al: Framework and development of a comprehensive drug product coding system. Cont Pharm Pract 1979;2:62-65.
13. 13. Shah BV, Folsom RE, Harrel FE, et al. RTILOGIT: procedure for logistic regression of survey data. Research Triangle Institute, Research Triangle Park, NC, 1987.
14. 14. Wilhelmsen L, Berglund G, Elmfedt D, et al: Beta-blockers versus diuretics in hypertensive men: main results of the HAPPHY trial. J Hypertens 1987;5:561-572.
15. 15. Wright JT, Jr., DiPette DJ, et al: Renin profile, race, and antihypertensive efficacy with atenolol and labetalol. J Hum Hypertens 1991;5:193-198.
16. 16. Dannenberg AL, Drizd T, Horan MJ, et al: Progress in the battle against hypertension. Changes in blood pressure levels in the United States from 1960 to 1980. Hypertension 1987;10:226-233.
17. 17. Systolic Hypertension in the Elderly Program, Pilot Study (SHEP-PS): Morbidity and mortality experience. J Hypertens 1986;4:S21-S23.
18. 18. Weiler PG, Camel GH, Chiappini M, et al: Systolic hypertension in the elderly program (SHEP) baseline characteristics of the randomized sample. IX. Behavioral characteristics. Hypertension 1991;17:s152-s161.
19. 19. Witteman JCM, Grobbee DE, Valkenburg HA, et al: J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet 1994;343:504-507.
20. 20. Langer RD, Ganiats TG, Barrett-Connor E: Paradoxical survival with higher blood pressures in older men. Br Med J 1989;298:1356-1357.
21. 21. Psaty BM, Savage PJ, Tell GS, et al: Temporal patterns of antihypertensive medication use among elderly patients. JAMA 1993;270:1837-1841.
22. 22. Materson BJ, Reda DJ, Cushman WC, et al: Single-drug therapy for hypertension in men. N Engl J Med 1993; 328:914-921.